GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (TSXV:HEM) » Definitions » Short-term investments

Hemostemix (TSXV:HEM) Short-term investments


View and export this data going back to 2012. Start your Free Trial

What is Hemostemix Short-term investments?

Short-term investments only applies to insurance companies.


Hemostemix Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SouthWest, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Executives
Peter Alan Lacey Director
Thomas Smeenk Director
Loran Swanberg Director
Blake Wood 10% Security Holder
Ravi Jain Senior Officer